Deficiencies of Magnesium Replacement in the Critically Ill

Abstract

Get full access to this article

View all access options for this article.

References

Raghu

Peddeswara Rao

Seshagiri Rao

. Protective effect of intravenous magnesium in acute myocardial infarction following thrombolytic therapy. Int J Cardiol. 1999;71(3):209–215.

Rasmussen

McNair

Norregard

Backer

Lindeneg

Balslev

. Intravenous magnesium in acute myocardial infarction. Lancet. 1986;1(8475):234–236.

Shechter

Hod

Chouraqui

Kaplinsky

Rabinowitz

. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol. 1995;75(5):321–323.

Woods

Fletcher

Roffe

Haider

. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1992;339(8809):1553–1558.

Hammond

Stojakovic

Kathe

. Effectiveness and safety of magnesium replacement in critically ill patients admitted to the medical intensive care unit in an academic medical center: a retrospective, cohort study [published online July 13, 2017]. J Intensive Care Med. 2017. doi:10.1177/0885066617720631.

Furlanetto

Faulhaber

. Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg. Arch Intern Med. 2011;171(15):1391–1392.